SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-018963
Filing Date
2022-09-28
Accepted
2022-09-28 16:12:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A eypt_defa14a_09-28-2022.htm DEFA14A 26814
2 GRAPHIC img24270469_0.jpg GRAPHIC 84692
3 GRAPHIC img24270469_1.jpg GRAPHIC 59583
  Complete submission text file 0000950170-22-018963.txt   226960
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-51122 | Film No.: 221276245
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services